Combining Neuroprotectants in a Model of Retinal Degeneration: No Additive Benefit

• Fabiana Di Marco ,

  * E-mail: dm.fabiana@hotmail.it

  Affiliation Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy

  ⨯
• Mattia Di Paolo,

  Affiliation Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy

  ⨯
• Stefania Romeo,

  Affiliation Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy

  ⨯
• Linda Colecchi,

  Affiliation Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy

  ⨯
• Lavinia Fiorani,

  Affiliation Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy

  ⨯
• Sharon Spana,

  Affiliation Discipline of Physiology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia

  ⨯
• Jonathan Stone,

  Affiliations Discipline of Physiology and Bosch Institute, University of Sydney, Sydney, New South Wales, Australia, ARC Centre of Excellence in Vision Science, The Australian National University, Canberra, Australia

  ⨯
• Silvia Bisti

  Affiliations Department of Biotechnology and Applied Clinical Science, University of L'Aquila, L'Aquila, Italy, ARC Centre of Excellence in Vision Science, The Australian National University, Canberra, Australia

  ⨯